CEACAM5 and breast cancer: In our study, the NLR, CEA, and CA153 levels showed an increasing trend after chemotherapy, and the levels of NLR and CA153 increased significantly in patients with BC with cognitive impairment (P = 0.015 and 0.022, respectively).